Simplify Propel Opportunities ETF (SURI) Holdings $16.54 +0.05 (+0.30%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatings Top 23 SURI HoldingsRankCompanyCurrent PriceWeightShares Held1PAGPPlains GP$18.20+0.7%23.69%1,272,3602APLTApplied Therapeutics$0.88-13.7%23.09%2,817,5053MDGLMadrigal Pharmaceuticals$308.44+5.1%7.38%23,2944AKROAkero Therapeutics$29.34+3.3%7.03%228,4545RNAAvidity Biosciences$31.82+2.5%5.18%125,0006TCRXTScan Therapeutics$2.97+1.4%4.77%1,046,9167CASHPathward Financial$73.62-0.6%4.63%4,840,2918PHATPhathom Pharmaceuticals$7.45-4.7%4.48%521,9359ARDXArdelyx$4.82+2.8%3.75%689,36410ABEOAbeona Therapeutics$5.70+1.2%2.50%408,58411TELSAT 6 1/2 10/15/27 CorpN/A1.92%6,124,00012SNDXSyndax Pharmaceuticals$13.08+1.8%1.89%120,00013TSATTelesat$17.23+2.6%1.83%145,49814TELSAT 5 5/8 12/06/26 CorpN/A1.39%2,700,00015KYMRKymera Therapeutics$40.66+3.9%1.37%30,51516ZVRAZevra Therapeutics$8.49-0.6%1.09%120,00017ACHVAchieve Life Sciences$3.69-3.4%0.94%217,84518ATHAAthira Pharma$0.58+5.1%0.93%1,492,79219KURAKura Oncology$9.01+0.4%0.85%80,00020Eiger BioPharmaceuticals, Inc.N/A0.73%90,00021CMPSCOMPASS Pathways$3.97+1.3%0.52%120,00022MaaT Pharma SAN/A0.03%3,15123CONTRA CHINOOK THERAPE + NPVN/A0.01%25,000 Geographic ExposureUnited States91.6%Currency ExposureUSD100.0%Sector ExposureEnergy31.1%Health Care16.6%Industry ExposureOil Gas & Consumable Fuels31.1%Biotechnology16.6%SubIndustry ExposureOil & Gas Storage & Transporta31.1%Biotechnology16.6% Related Companies and Tools Related Companies RXL Top Holdings XHS Top Holdings LABD Top Holdings BIB Top Holdings LFSC Top Holdings SBIO Top Holdings IBBQ Top Holdings KURE Top Holdings PTH Top Holdings BBP Top Holdings This page (NYSEARCA:SURI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Propel Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
